Terbinafine-induced subacute cutaneous lupus erythematosus
DOI:
https://doi.org/10.1080/00015550410018361Abstract
Oral terbinafine is licensed for use in onychomycosis after positive confirmation of infection. We describe five cases of subacute cutaneous lupus erythematosus associated with terbinafine therapy. All cases had positive antibodies to extractable nuclear antigens, predominantly anti-Ro, and several had a history of pre-existing autoimmune disease. Terbinafine should only be prescribed after confirmation of infection by microscopy or culture.Downloads
Download data is not yet available.
Downloads
Published
2005-04-23
How to Cite
McKay DA, S. O. (2005). Terbinafine-induced subacute cutaneous lupus erythematosus. Acta Dermato-Venereologica, 84(6), 472–474. https://doi.org/10.1080/00015550410018361
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
